Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.E. Tracy.
Sex differences in coronary disease: two opposing view.
J Chron Dis, 19 (1966), pp. 1245-1251
[2.]
M.F. Kalim, B. Zumoff.
Sex hormones and coronary disease: a review of the clinical studies.
Steroids, 55 (1990), pp. 330-352
[3.]
H. Tunstall-Pedoe.
Myth and paradox of coronary risk and the menopause.
Lancet, 351 (1998), pp. 1425-1427
[4.]
E. Barrett-Connor, T.L. Bush.
Estrogen and coronary heart disease in women.
JAMA, 265 (1991), pp. 1861-1867
[5.]
D. Grady, S.M. Rubin, D.B. Pettiti, et al.
Hormone herapy to prevent disease and prolong life in postmenopausal women.
Ann Intern Med, 117 (1992), pp. 1016-1037
[6.]
E. Barrett-Connor.
An epidemiological looks at hormones and heart disease.
J Clin Endocrinol Metabol, 88 (2003), pp. 4031-4042
[7.]
S. Hulley, D. Grady, T. Bush, et al.
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research group.
JAMA, 280 (1998), pp. 605-613
[8.]
D. Grady, D. Herrington, V. Bittner, et al.
ardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
JAMA, 288 (2002), pp. 49-57
[9.]
S.C. Clarke, J. Kelleher, H. Lloyd-Jones, et al.
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.
BJOG, 109 (2002), pp. 1056-1062
[10.]
D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, et al.
Effects of estrogen replacement on the progression of coronary artery atherosclerosis.
N Engl J Med, 343 (2000), pp. 522-529
[11.]
D.D. Waters, E.L. Alderman, J. Hsia, et al.
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
JAMA, 288 (2002), pp. 2432-2440
[12.]
N. Cherry, K. Gilmour, P. Hannaford, et al.
Oestrogen therapy for prevention of reinfartion in postmenopausal women: a randomized placebo controlled trial.
Lancet, 360 (2002), pp. 2001-2028
[13.]
J.E. Rossouw, G.I. Anderson, R.I. Prentice, et al.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.
JAMA, 288 (2002), pp. 321-333
[14.]
G.I. Anderson, M. Limacher, A.R. Assaf, et al.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women Health Initiative randomized controlled trial.
JAMA, 291 (2004), pp. 1701-1712
Copyright © 2005. Elsevier España S.L. Barcelona
